John Holder, MD
Interventional Pain Medicine · Hampstead, NCNPI 1093949463
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,101 of the $9,327 with a category attached, or 76.1%. 34 manufacturers reported payments, led by Boston Scientific at 29.7% of the total. Reporting peaked in 2022 at $2,765 and has fallen 69.4% since, to $846 in 2025.
Across 407 payments — averaging $22.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Medtronic$2K
- AbbVie$1K
- Abbott$543
- Amgen$384
- Pfizer$323
- plus $2K from 28 others
What the payments were for
- Travel & lodging$2,22624%
- Food & beverage$7,10176%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 69 | $2,768 |
| Medtronic(2 entities) | 87 | $2,381 |
| AbbVie(2 entities) | 81 | $1,038 |
| Abbott | 29 | $543 |
| Amgen(2 entities) | 19 | $384 |
| Pfizer | 22 | $323 |
| Nevro Corp. | 7 | $148 |
| Collegium Pharmaceutical, Inc. | 9 | $146 |
| Biohaven Pharmaceuticals, Inc. | 8 | $120 |
| Virtus Pharmaceuticals LLC | 6 | $117 |
| Forte Bio-pharma LLC | 3 | $117 |
| Globus Medical | 4 | $109 |
| Redhill Biopharma Inc. | 6 | $109 |
| Teva Pharmaceuticals USA, Inc. | 7 | $101 |
| Si-bone, Inc. | 3 | $95 |
| Lilly USA, LLC | 6 | $86 |
| Lundbeck LLC | 4 | $74 |
| Merz Pharmaceuticals, LLC | 3 | $74 |
| MDD US Operations, LLC | 4 | $70 |
| Painteq LLC | 2 | $66 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $65 |
| Daiichi Sankyo Inc. | 3 | $54 |
| Arbor Pharmaceuticals, Inc. | 3 | $51 |
| Almatica Pharma LLC | 2 | $43 |
| Kowa Pharmaceuticals America, Inc. | 3 | $43 |
| IBSA Pharma Inc. | 2 | $37 |
| AstraZeneca | 2 | $26 |
| Kaleo, Inc. | 2 | $25 |
| Stryker | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $24 |
| Bioventus LLC | 1 | $22 |
| Tersera Therapeutics LLC | 1 | $16 |
| Novo Nordisk | 1 | $15 |
| Pernix Therapeutics Holdings, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,327 in reported general payments places this provider in the 75th percentile of 45 interventional pain medicine providers in North Carolina.
See all interventional pain medicine providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ButransBuprenorphine | 23 | $11,691 |
| Oxycodone Hcl | 140 | $6,631 |
| Buprenorphine Hcl | 68 | $6,228 |
| Hysingla ErHydrocodone Bitartrate | 12 | $6,035 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 42 | $4,840 |
| Buprenorphine | 29 | $4,043 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 132 | $3,457 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 120 | $2,153 |
| Morphine Sulfate | 38 | $1,584 |
| Pregabalin | 71 | $1,558 |
| Fentanyl | 21 | $1,520 |
| Duloxetine Hcl | 20 | $514 |
| Morphine Sulfate ErMorphine Sulfate | 14 | $496 |
| Hydromorphone Hcl | 18 | $445 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 17 | $404 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Hampstead
- Timothy ChafinAhoskie$59K
- Robert WilsonSalisbury$37K
- John MansfieldAsheville$25K
- Erin ChaneyJacksonville$22K
- Kevin CostelloGreenville$22K
- Scott JohnstonJacksonville$20K
- Harsh GovilStatesville$19K
- Troy GingerichCharlotte$19K
- Brent HarkriderNew Bern$14K
- Carey-Walter ClossonCharlotte$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.